Immune and targeted therapies with radiation therapy improves outcomes for melanoma brain metastases patients
Brain metastases are one of the most common complications of advanced melanoma, requiring multidisciplinary management. Patients who are diagnosed with these metastases have an expected median survival of only 4 to 5 months. ...
Sep 21, 2016